Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
iShares Russell Mid-Cap ETF
IWR
$57.9B
| – | – |
-5,800
| Closed | -$313K |
|
3652
iShares US Energy ETF
IYE
$1.79B
| – | – |
-7,500
| Closed | -$270K |
|
3653
Jack Henry & Associates
JKHY
$10.8B
| – | – |
-44,419
| Closed | -$6.16M |
|
3654
Jones Lang LaSalle
JLL
$16.8B
| – | – |
-23,100
| Closed | -$3.56M |
|
|
KALV
3655
DELISTED
KalVista Pharmaceuticals
KALV
| – | – |
-159,929
| Closed | -$4.58M |
|
|
OPLN
3656
Openlane
OPLN
$4.26B
| – | – |
-418,229
| Closed | -$8.12M |
|
3657
KB Financial Group
KB
$41.4B
| – | – |
-18,700
| Closed | -$693K |
|
3658
KeyCorp
KEY
$24.5B
| – | – |
-30,700
| Closed | -$484K |
|
3659
KKR & Co
KKR
$98.6B
| – | – |
-747,350
| Closed | -$17.6M |
|
3660
KLA
KLAC
$272B
| – | – |
-8,107,750
| Closed | -$96.8M |
|
3661
Krystal Biotech
KRYS
$9.86B
| – | – |
-30,800
| Closed | -$1.01M |
|
3662
Key Tronic
KTCC
$41.4M
| – | – |
-27,000
| Closed | -$167K |
|
3663
Lazard
LAZ
$4.23B
| – | – |
-289,900
| Closed | -$10.5M |
|
3664
L3Harris
LHX
$52.9B
| – | – |
-231,459
| Closed | -$37M |
|
3665
Lumentum
LITE
$73.2B
| – | – |
-35,852
| Closed | -$2.03M |
|
3666
LivaNova
LIVN
$4.48B
| – | – |
-367,822
| Closed | -$35.8M |
|
3667
Live Oak Bancshares
LOB
$1.99B
| – | – |
-26,800
| Closed | -$392K |
|
|
3668
Lowe's Companies
LOW
$121B
| – | – |
-2,493,390
| Closed | -$273M |
|
3669
Lumen
LUMN
$6.53B
| – | – |
-2,741,603
| Closed | -$32.9M |
|
3670
Mastercard
MA
$488B
| – | – |
-526,549
| Closed | -$124M |
|
3671
Mattel
MAT
$4.27B
| – | – |
-1,813,275
| Closed | -$23.6M |
|
3672
Matsons
MATX
$6.38B
| – | – |
-34,600
| Closed | -$1.25M |
|
3673
Moelis & Co
MC
$4.9B
| – | – |
-106,344
| Closed | -$4.42M |
|
3674
McDonald's
MCD
$194B
| – | – |
-965,700
| Closed | -$183M |
|
3675
iShares MSCI China ETF
MCHI
$6.21B
| – | – |
-15,800
| Closed | -$986K |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.